Baxter International Inc.
BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care productā¦ read more
Healthcare
Medical Instruments & Supplies
44 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$28.10
Price+7.42%
$1.94
1Y
Price
Market Cap
$14.528b
Large
Price/Earnings 3y Avg5y Avg
13.5x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+16.0%
EBITDA Margin+4.3%
Net Profit Margin+1.1%
Free Cash Flow Margin+16.0%
EBITDA Margin+4.3%
Net Profit Margin+1.1%
Free Cash Flow MarginRevenue
$11.470b
+2.0%
1y CAGR+3.5%
3y CAGR+3.4%
5y CAGREarnings
-$1.063b
-11.1%
1y CAGR-61.0%
3y CAGR+6.6%
5y CAGREPS
-$2.04
-16.6%
1y CAGR-59.5%
3y CAGR+7.4%
5y CAGRBook Value
$6.179b
$19.791b
Assets$13.612b
Liabilities$9.667b
DebtDebt to Assets
48.9%
12.9x
Debt to EBITDAFree Cash Flow
$678m
+109.9%
1y CAGR+3.7%
3y CAGR+33.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company